Thrombocytopenic patients with hematological malignancy who underwent fiberoptic bronchoscopy are they really under a significant hemorrhagic risk?

Abstract Background Fiberoptic bronchoscopy (FOB) is a very important procedure in hematology clinics. Clinicians often worry about thrombocytopenia before performing FOB because hemorrhagic complications may occur during and after FOB. We have planned retrospective study thrombocytopenic patients who underwent treated for hematological malignancy. In this study, we analyzed complications, which are related to thrombocytopenia, 114 adult hematologic malignancy between January 1, 2005 October 20, 2015. The platelet counts of all the were below 100 × 10 9 /L. Results observed 4 (3.5%) out patient. Three hemorrhage. One these 3 occured hemorrhage was “no bleeding group” according BTS classification. other 1 “mild bleeding” group. No third Hemoptysis patient, it not required replacement hemoptysis regressed spontaneously. categorized into three groups. first group comprised 32 whose 0 30 second 47 platelets 50 /L lastly, 35 When compared groups each other, there no significant difference regards occurrence complications. that relationship level risk Conclusions conclusion, demonstrated safe procedures if performed multidisciplinary centers by experienced pulmonologists.